Mineralys Therapeutics, Inc. MLYS
NASDAQ · United States · Health Technology
$24.70-0.43 (-1.73%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -2.85 | -0.55 | -419.5% | $0 | — | -1.2%$27.38→$27.05 |
| Q1 2026 | 2026-05-06 | -0.47 | -0.51 | +7.8% | — | — | +0.2%$29.28→$29.35 |
| Q4 2025 | 2026-03-12 | -0.40 | -0.52 | +23.1% | — | — | -6.4%$27.97→$26.19 |
| Q3 2025 | 2025-11-10 | -0.52 | -0.61 | +14.8% | — | — | +23.9%$38.02→$47.11 |
| Q2 2025 | 2025-08-12 | -0.66 | -0.74 | +10.8% | — | — | — |
| Q1 2025 | 2025-05-12 | -0.79 | -0.98 | +19.4% | — | — | — |
| Q4 2024 | 2025-02-12 | -0.98 | -1.08 | +9.3% | — | — | — |
| Q3 2024 | 2024-11-11 | -1.13 | -0.83 | -36.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.